Heterodimeric IL-15 in Cancer Immunotherapy

SIMPLE SUMMARY: The rapidly expanding field of cancer immunotherapy uses diverse technologies, including cytokines, T cells, and antibody administration, with the aim to induce effective immune responses leading to tumor control. Interleukin-15 (IL-15), a cytokine discovered in 1994, supports the ho...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Bergamaschi, Cristina, Stravokefalou, Vasiliki, Stellas, Dimitris, Karaliota, Sevasti, Felber, Barbara K., Pavlakis, George N.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7922495/
https://ncbi.nlm.nih.gov/pubmed/33671252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040837
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki